Nanoviricides (NNVC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.38, +0.73% vs the prior close of $1.37.
- Volume 154.85K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NNVC rises 0.7% to $1.38. Closed at $1.38, +0.73% vs the prior close of $1.37. Day range $1.34–$1.40, opened at $1.36.
NNVC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NNVC rises 0.7% to $1.38
- Closed at $1.38, +0.73% vs the prior close of $1.37. Day range $1.34–$1.40, opened at $1.36.
- Volume was 154.85K shares, 0.4x its 50-day average of 439.55K — lighter than usual.
- Price is +5.6% vs its 50-day average ($1.31) and +7.9% vs its 200-day average ($1.28).
- 52-week range $0.85–$2.23; today's close sits at 38% of that range, 38.1% below the 52-week high.
Oct 15, 2026 — NNVC jumps 4.6% to $1.37
- Closed at $1.37, +4.58% vs the prior close of $1.31. Day range $1.30–$1.40, opened at $1.30.
- Volume was 198.50K shares, 0.5x its 50-day average of 440.50K — lighter than usual.
- Price is +4.8% vs its 50-day average ($1.31) and +7.2% vs its 200-day average ($1.28).
- 52-week range $0.85–$2.23; today's close sits at 38% of that range, 38.6% below the 52-week high.
Oct 14, 2026 — NNVC dips 0.8% to $1.31
- Closed at $1.31, -0.76% vs the prior close of $1.32. Day range $1.28–$1.34, opened at $1.32.
- Volume was 150.20K shares, 0.3x its 50-day average of 443.44K — lighter than usual.
- Price is +0.1% vs its 50-day average ($1.31) and +2.6% vs its 200-day average ($1.28).
- 52-week range $0.85–$2.23; today's close sits at 33% of that range, 41.3% below the 52-week high.
Oct 13, 2026 — NNVC jumps 3.1% to $1.32
- Closed at $1.32, +3.13% vs the prior close of $1.28. Day range $1.24–$1.34, opened at $1.24.
- Volume was 240.10K shares, 0.5x its 50-day average of 448.85K — lighter than usual.
- Price is +0.6% vs its 50-day average ($1.31) and +3.5% vs its 200-day average ($1.28).
- 52-week range $0.85–$2.23; today's close sits at 34% of that range, 40.8% below the 52-week high.
Oct 12, 2026 — NNVC dips 1.5% to $1.28, 3 down days in a row
- Closed at $1.28, -1.54% vs the prior close of $1.30. Day range $1.27–$1.33, opened at $1.31.
- Volume was 132.90K shares, 0.3x its 50-day average of 448.85K — lighter than usual.
- Price is -2.8% vs its 50-day average ($1.32) and +0.4% vs its 200-day average ($1.28).
- 52-week range $0.85–$2.23; today's close sits at 31% of that range, 42.6% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — NNVC dips 0.8% to $1.30
- Closed at $1.30, -0.76% vs the prior close of $1.31. Day range $1.30–$1.40, opened at $1.33.
- Volume was 169.50K shares, 0.4x its 50-day average of 448.92K — lighter than usual.
- Price is -1.6% vs its 50-day average ($1.32) and +2.0% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 33% of that range, 41.7% below the 52-week high.
Oct 8, 2026 — NNVC slides 9.0% to $1.31
- Closed at $1.31, -9.03% vs the prior close of $1.44. Day range $1.30–$1.42, opened at $1.38.
- Volume was 298.60K shares, 0.7x its 50-day average of 446.33K.
- Price is -1.3% vs its 50-day average ($1.33) and +2.8% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 33% of that range, 41.3% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 7, 2026 — NNVC rises 2.9% to $1.44
- Closed at $1.44, +2.86% vs the prior close of $1.40. Day range $1.40–$1.50, opened at $1.43.
- Volume was 305.90K shares, 0.7x its 50-day average of 452.69K.
- Price is +8.2% vs its 50-day average ($1.33) and +13.0% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 43% of that range, 35.4% below the 52-week high.
Oct 6, 2026 — NNVC slides 3.4% to $1.40
- Closed at $1.40, -3.45% vs the prior close of $1.45. Day range $1.36–$1.48, opened at $1.45.
- Volume was 301.90K shares, 0.7x its 50-day average of 455.99K.
- Price is +4.9% vs its 50-day average ($1.33) and +10.0% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 40% of that range, 37.2% below the 52-week high.
Oct 5, 2026 — NNVC jumps 13.3% to $1.45
- Closed at $1.45, +13.28% vs the prior close of $1.28. Day range $1.28–$1.50, opened at $1.29.
- Volume was 704.40K shares, 1.6x its 50-day average of 448.19K.
- Price is +8.4% vs its 50-day average ($1.34) and +14.0% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 43% of that range, 35.0% below the 52-week high.
Oct 2, 2026 — NNVC rises 1.6% to $1.28
- Closed at $1.28, +1.59% vs the prior close of $1.26. Day range $1.23–$1.30, opened at $1.25.
- Volume was 239.50K shares, 0.5x its 50-day average of 449.67K — lighter than usual.
- Price is -4.3% vs its 50-day average ($1.34) and +0.7% vs its 200-day average ($1.27).
- 52-week range $0.85–$2.23; today's close sits at 31% of that range, 42.6% below the 52-week high.
NNVC latest news & SEC filings
Every SEC filing by or about NNVC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 28, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$8.22M (prior year -$9.47M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.41 (prior year -$0.63) (loss narrowed vs Jun 30, 2025)
Sep 3, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 31, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 21, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jul 27, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 27, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 17, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 1, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 26, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jun 23, 2026 · Form CORRESP — Company letter to the SEC
Company letter to the SEC
Jun 22, 2026 · Form DEL AM — DEL AM filing
DEL AM filing
Things to know before you trade NNVC
- How much it moves: over the last 20 sessions the average daily move was 4.83% (largest 19.0%). That is a volatile stock.
- Liquidity: about 464.58K shares (≈$641.12K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.38 vs a range of $0.85–$2.23 (38% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 10-K Sep 28, 2026; 8-K Jul 30, 2026.
- Share count: 25.52M shares outstanding (Sep 28, 2026), +46.4% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
NNVC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.36 | 1.40 | 1.34 | 1.38 | 154.85K |
| Oct 15, 2026 | 1.30 | 1.40 | 1.30 | 1.37 | 198.50K |
| Oct 14, 2026 | 1.32 | 1.34 | 1.28 | 1.31 | 150.20K |
| Oct 13, 2026 | 1.24 | 1.34 | 1.24 | 1.32 | 240.10K |
| Oct 12, 2026 | 1.31 | 1.33 | 1.27 | 1.28 | 132.90K |
| Oct 9, 2026 | 1.33 | 1.40 | 1.30 | 1.30 | 169.50K |
| Oct 8, 2026 | 1.38 | 1.42 | 1.30 | 1.31 | 298.60K |
| Oct 7, 2026 | 1.43 | 1.50 | 1.40 | 1.44 | 305.90K |
| Oct 6, 2026 | 1.45 | 1.48 | 1.36 | 1.40 | 301.90K |
| Oct 5, 2026 | 1.29 | 1.50 | 1.28 | 1.45 | 704.40K |
| Oct 2, 2026 | 1.25 | 1.30 | 1.23 | 1.28 | 239.50K |
| Oct 1, 2026 | 1.30 | 1.30 | 1.25 | 1.26 | 205.10K |
| Sep 30, 2026 | 1.36 | 1.41 | 1.26 | 1.30 | 425.00K |
| Sep 29, 2026 | 1.52 | 1.56 | 1.28 | 1.30 | 968.20K |
| Sep 28, 2026 | 1.44 | 1.53 | 1.40 | 1.50 | 632.70K |
| Sep 25, 2026 | 1.44 | 1.49 | 1.43 | 1.44 | 413.00K |
| Sep 24, 2026 | 1.50 | 1.55 | 1.42 | 1.44 | 461.60K |
| Sep 23, 2026 | 1.62 | 1.64 | 1.51 | 1.51 | 316.10K |
| Sep 22, 2026 | 1.70 | 1.77 | 1.52 | 1.53 | 1.29M |
| Sep 21, 2026 | 1.50 | 1.78 | 1.49 | 1.69 | 1.68M |
About Nanoviricides
Nanoviricides (NNVC) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SHELTON, CT. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1379006.
NNVC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NNVC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-8.22M | -0.41 | $-7.70M |
| Jun 30, 2025 | — | $-9.47M | -0.63 | $-8.48M |
| Jun 30, 2024 | — | $-8.29M | -0.70 | $-6.32M |
| Jun 30, 2023 | — | $-8.59M | -0.74 | $-5.67M |
| Jun 30, 2022 | — | $-8.11M | -0.70 | $-5.89M |
Latest balance sheet: total assets $9.87M, total liabilities $1.20M, cash $2.79M (as of Jun 30, 2026).
NNVC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NNVC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.